ArticleCell reports. Medicine2022

Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer.

Zemin Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.